Q2 2025 Hester Biosciences Ltd Earnings Call Transcript
Key Points
- Hester Biosciences Ltd (BOM:524669) reported a 27% increase in divisional product sales for the first half of FY25 compared to the previous year.
- The animal healthcare division saw a 20% growth in H1 FY25, driven by sustained demand in the dairy sector.
- The poultry healthcare division achieved a 27% growth in H1 FY25, with a 59% increase in exports of poultry vaccines.
- The pet care division reported a 20% growth in H1 FY25, with the successful launch of a new prescription-based pet food diet.
- Gross profit margins improved by 6% in H1 FY25 due to a favorable product mix, leading to a 4% improvement in EBITDA margin.
- The overall revenue from operations appeared flat due to one-time sales in Q1 of the previous year.
- Despite growth, the animal healthcare division only registered a modest 4% growth in Q2 FY25.
- The company is still working on reducing losses in its African operations, despite positive topline growth.
- The pet care division, while promising, currently lacks vaccine products, which are a core part of Hester's business.
- The company faces a challenging market environment in certain areas, which could impact future growth.
Ladies and gentlemen, good day. And welcome to the Hester Bioscience Q2 H1 FY25 earnings conference call hosted by ICICI Securities. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call? Please signal an operator by pressing star then zero on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to MS Priya Gandhi from ICICI Securities Limited. Thank you and over to you, ma'am.
Thank you, Good afternoon, everyone on behalf of it security. I welcome you all on Q2 F 525 earnings conference call of Biosciences. And I thank the Hester Biosciences management team for giving us this opportunity to host this call today on this call we have with us Mr Rajiv Gandhi CEO and managing director, Miss Priya Gandhi, executive director, Mr Nikhil Java CFO. I will now hand over the call to the Hester management team for the opening remarks. Thank you
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
